These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39267713)

  • 1. Interval-specific censoring set adjusted Kaplan-Meier estimator.
    Wu Y; Kolassa J
    J Appl Stat; 2024; 51(12):2436-2456. PubMed ID: 39267713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.
    Fay MP; Brittain EH; Proschan MA
    Biostatistics; 2013 Sep; 14(4):723-36. PubMed ID: 23632624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules.
    Eaton AA; Zabor EC
    Stat Med; 2022 Apr; 41(9):1599-1612. PubMed ID: 35043427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kaplan-Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average.
    Satten GA; Datta S
    Am Stat; 2001; 55(3):207-210. PubMed ID: 28845048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for Improving the Variance Estimator of the Kaplan-Meier Survival Function, When There Is No, Moderate and Heavy Censoring-Applied in Oncological Datasets.
    Khan HN; Zaman Q; Azmi F; Shahzada G; Jakovljevic M
    Front Public Health; 2022; 10():793648. PubMed ID: 35692348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation and testing for clustered interval-censored bivariate survival data with application using the semi-parametric version of the Clayton-Oakes model.
    Rosner B; Bay C; Glynn RJ; Ying GS; Maguire MG; Lee MT
    Lifetime Data Anal; 2023 Oct; 29(4):854-887. PubMed ID: 36670299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast approximations of pseudo-observations in the context of right censoring and interval censoring.
    Bouaziz O
    Biom J; 2023 Apr; 65(4):e2200071. PubMed ID: 36843309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Left-Censored Data Through Substitution, Parametric, Semi-parametric, and Nonparametric Methods: A Simulation Study.
    Tekindal MA; Erdoğan BD; Yavuz Y
    Interdiscip Sci; 2017 Jun; 9(2):153-172. PubMed ID: 26590921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation with interval censored data and covariates.
    Van der Laan MJ; Hubbard A
    Lifetime Data Anal; 1997; 3(1):77-91. PubMed ID: 9384627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted log-rank test to compare two survival functions in the presence of dependent censoring.
    Flandre P
    Pharm Stat; 2022 Nov; 21(6):1281-1293. PubMed ID: 35708191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Expectation-Maximization Algorithm for Including Oncological COVID-19 Deaths in Survival Analysis.
    De Felice F; Mazzoni L; Moriconi F
    Curr Oncol; 2023 Feb; 30(2):2105-2126. PubMed ID: 36826124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighted Kaplan-Meier estimators motivating to estimate HIV-1 RNA reduction censored by a limit of detection.
    Ahmed I; Flandre P
    Stat Med; 2020 Mar; 39(7):968-983. PubMed ID: 31981243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis using auxiliary variables via non-parametric multiple imputation.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression models for interval censored data using parametric pseudo-observations.
    Johansen MN; Lundbye-Christensen S; Larsen JM; Parner ET
    BMC Med Res Methodol; 2021 Feb; 21(1):36. PubMed ID: 33588771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.